These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9755928)

  • 1. Metronidazole has no antibacterial effect in Cornell model murine tuberculosis.
    Dhillon J; Allen BW; Hu YM; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):736-42. PubMed ID: 9755928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
    Hu Y; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The curious characteristics of pyrazinamide: a review.
    Zhang Y; Mitchison D
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):6-21. PubMed ID: 12701830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.
    Wayne LG; Sramek HA
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2054-8. PubMed ID: 7811018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
    Karakousis PC; Williams EP; Bishai WR
    J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.
    Murugasu-Oei B; Dick T
    J Antimicrob Chemother; 2000 Dec; 46(6):917-9. PubMed ID: 11102410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
    Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
    Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
    Wade MM; Zhang Y
    J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable cure for tuberculosis: rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection.
    Shoen CM; DeStefano MS; Cynamon MH
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S288-90. PubMed ID: 10875802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
    Cardona PJ; Amat I; Gordillo S; Arcos V; Guirado E; Díaz J; Vilaplana C; Tapia G; Ausina V
    Vaccine; 2005 Feb; 23(11):1393-8. PubMed ID: 15661388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium.
    Dhillon J; Lowrie DB; Mitchison DA
    BMC Infect Dis; 2004 Nov; 4():51. PubMed ID: 15548322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
    N'guessan K; Dosso M; Marchal G; Chavarot P; Romain F; Pescher P; Edy
    Bull Soc Pathol Exot; 2002 Nov; 95(4):265-8. PubMed ID: 12596375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute-phase reactants during murine tuberculosis: unknown dimensions and new frontiers.
    Singh PP; Kaur S
    Tuberculosis (Edinb); 2005; 85(5-6):303-15. PubMed ID: 16275064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.